Diagnosis and Treatment of Systemic Mastocytosis With an Associated Hematologic Neoplasm
Nathan A. Boggs, MD
Tracy George, MD
Lindsay Rein, MD
The Pathologist Perspective: Identifying Systemic Mastocytosis in the Community
Accurate Diagnosis and Management of Hereditary Alpha Tryptasemia
Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC
Sarah Sammons, MD
Carey Anders, MD, FASCO
Understanding CNS Lesions in HER2+ Metastatic Breast Cancer
Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches
HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
Optimizing Treatment Selection for HER2+ Breast Cancer Patients with Brain Metastases
Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC
Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
Heather McArthur, MD
Margaret Gatti-Mays, MD, MPH
Case Application: Patients With EGFRm Resistance Post TKI and Platinum Chemotherapy
Pasi Antero Jänne, MD, PhD
Helena Yu, MD
HER3-Directed ADCs in the Treatment of EGFR-Mutated Advanced or Metastatic NSCLC Progressing on TKI and Platinum-Based Chemotherapy
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
Overcoming EGFR Resistance With HER3-Directed ADCs
Biologic Rationale for Targeting HER3 and Role in EGFR Resistance
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.